2012 Scrip 100: Successful trial outcomes – peering into the crystal ball
This article was originally published in Scrip
With rising trial costs and shrinking budgets, pharma companies are working more diligently than ever to identify keys to success in the clinic. But without the benefit of the proverbial crystal ball, the industry must rely on examining historical records as predictors or benchmarks of future performance. Susan Danheiser and the Citeline Analytics team begin to explore this notion, and outline key findings from a retrospective analysis of clinical trial outcomes in six therapeutic areas.